Trial Bolsters Three Drug Combination Treatment as Standard After First Multiple Myeloma Relapse

Published Jun 7, 2019

Trial Bolsters Three Drug Combination Treatment as Standard After First Multiple Myeloma Relapse

A new trial confirms the effectiveness of pomalidomide in treating lenalidomide resistant multiple myeloma

NOW
PLAYING
CAR T-Cell Therapy for Non-Hodgkin Lymphoma
NOW
PLAYING
Given Just 18 Months to Live, This Lung Cancer Survivor Proves the Power of Clinical Trials
NOW
PLAYING
What Is Dexamethasone? The Common Cancer Treatment Is Proving Beneficial for COVID-19 Patients
NOW
PLAYING
6 Common Excuses for Skipping a Mammogram That You Need to Stop Using!
NOW
PLAYING
New PARP Inhibitor Combination Approved for Ovarian Cancer
NOW
PLAYING
As Eddie Van Halen Battles Throat Cancer, New Book Details ‘Decades of White-Knuckle Rock’
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.